Finni Health vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
ABA therapy practice management platform with instant insurance credentialing and billing; $3.32M from General Catalyst and YC with 50% MoM growth competing with CentralReach.
About
Finni Health is a healthcare technology platform providing business infrastructure for autism therapy providers — offering instant insurance credentialing, patient data management, billing automation, and payment processing that allows ABA (Applied Behavior Analysis) therapy practices to launch and scale without the administrative overhead that typically requires a full billing and operations team. Founded in 2023 and backed by $3.32 million led by General Catalyst and Y Combinator, Finni Health serves providers across five states and achieved $30,000 in monthly revenue with 50% month-over-month growth within seven months of launch.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.